TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds

Clinical trial NCT02737748 · COMPLETED

Trial details

NCT number: NCT02737748
Sponsor: Transwell Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Donor Site Complication

Start date: 2017-07-06
Primary completion: 2021-05-07
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.